Search Result "Avastin®"
177Lu-DOTA-Bevacizumab: Radioimmunotherapy Agent for Melanoma
Journal: Current Radiopharmaceuticals
Volume: 10 Issue: 1 Year: 2017 Page: 21-28
Author(s): Ximena Camacho,Victoria Calzada,Marcelo Fernandez,Omar Alonso,Roger Chammas,Eloisa Riva,Juan Pablo Gambini,Pablo Cabral
Corneal Neovascularization: Molecular Events and Therapeutic Options
Journal: Recent Patents on Inflammation & Allergy Drug Discovery
Volume: 3 Issue: 3 Year: 2009 Page: 221-231
Author(s): Yadollah Shakiba, Kamran Mansouri, Delnia Arshadi, Nima Rezaei
Practical Aspects in the Use of Biomarkers for the Development of Cancer Vaccines
Journal: Current Cancer Therapy Reviews
Volume: 4 Issue: 2 Year: 2008 Page: 161-165
Author(s): Angus G. Dalgleish
Angiotensin-I Converting Enzyme Inhibitors as Potential Anti-Angiogenic Agents for Cancer Therapy
Journal: Current Cancer Drug Targets
Volume: 4 Issue: 7 Year: 2004 Page: 555-567
Author(s): Hitoshi Yoshiji, Shigeki Kuriyama, Ryuichi Noguchi, Hiroshi Fukui
Manipulation of the Immune System for Cancer Defeat: A Focus on the T Cell Inhibitory Checkpoint Molecules
Journal: Current Medicinal Chemistry
Volume: 27 Issue: 15 Year: 2020 Page: 2402-2448
Author(s): Paolo DâArrigo,Martina Tufano,Anna Rea,Vincenza Vigorito,Nunzia Novizio,Salvatore Russo,Maria Fiammetta Romano,Simona Romano
Therapeutic Proteins in Tumors and Targeted Therapeutic Agents for Cancer Patients
Journal: Protein & Peptide Letters
Volume: 20 Issue: 1 Year: 2013 Page: 1345-1359
Author(s): S. Altug Kesikli, Saadettin Kilickap
The Immune System and Immune Network
Ebook: Medicinal Chemistry - Fusion of Traditional and Western Medicine
Volume: 3 Year: 2015
Author(s): Robert E. Smith
Doi: 10.2174/9781681080789115030011